← Back to Search

Restricted Sleep Impact on Brain Health

N/A
Recruiting
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two days
Awards & highlights

Study Summary

This trial will compare how normal and restricted sleep affects brain blood flow in healthy men and women. Participants will complete 3 visits.

Who is the study for?
This trial is for healthy men and women aged 18-45 with a BMI of 18-30, who don't use nicotine and aren't pregnant or breastfeeding. It's not for those with recent major heart events, high blood pressure, sleep-affecting meds, or history of liver, kidney, lung diseases; stroke; bleeding disorders; sleep apnea; diabetes; or substance abuse.Check my eligibility
What is being tested?
The study looks at how restricted sleep affects brain blood flow in healthy adults. Participants will have their cerebral blood flow velocity measured after normal and restricted sleep nights to see if there's a difference and if the effect varies between males and females over two separate days.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring rather than medication or invasive procedures, significant side effects are not anticipated. However, participants may experience fatigue due to sleep restriction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two days
This trial's timeline: 3 weeks for screening, Varies for treatment, and two days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cerebral blood flow velocity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Restricted sleepExperimental Treatment1 Intervention
Participants will restrict sleep to four hours the night prior to the study visit.
Group II: Normal sleepPlacebo Group1 Intervention
Participants will sleep for 7-9 hours the night prior to the study visit.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
367 Previous Clinical Trials
628,397 Total Patients Enrolled
~0 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top